Article

Higher Gout Prevalence With Growth in Obesity and Hypertension

The prevalence of gout in the United States has risen over the past 20 years and now affects 8.3 million Americans, or 4% of the population, according to a study reported in a recent issue of Arthritis & Rheumatism, an American College of Rheumatology (ACR) publication.

The prevalence of gout in the United States has risen over the past 20 years and now affects 8.3 million Americans, or 4% of the population, according to a study reported in a recent issue of Arthritis & Rheumatism, an American College of Rheumatology (ACR) publication. Higher frequencies of obesity and hypertension in recent years may be contributing factors. The prevalence of hyperuricemia also increased, affecting 43.3 million American adults.

Researchers compared data from the latest US National Health and Nutrition Examination Survey (NHANES) (2007 and 2008) with those from previous NHANES surveys (1988 to 1994). The survey included questions about a history of gout with a diagnosis made by a health care professional; there were 5707 participants. Hyperuricemia was defined as a serum urate level higher than 7.0 mg/dL in men and 5.7 mg/dL in women.

The frequencies of gout and hyperuricemia were 1% and 3% higher, respectively, in the current NHANES report than in the earlier one, although the differences in prevalence rates were substantially lessened after adjusting for obesity or hypertension. Gout prevalence was higher in men (6%) than in women (2%); hyperuricemia occurred in 21.2% of men and 21.6% of women.

The researchers concluded that the prevalences of gout and hyperuricemia continue to be substantial in the US adult population. They suggested that improvements in management of modifiable risk factors, such as obesity and hypertension, could help prevent further escalation of gout and hyperuricemia in Americans.

For more information about gout and other rheumatologic conditions, visit the ACR Web site at http://www.rheumatology.org. Or, contact the organization at American College of Rheumatology, 2200 Lake Boulevard NE, Atlanta, GA 30319; telephone: (404) 633-3777; fax: (404) 633-1870.

Related Videos
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
Laure Gossec, MD, PhD: Informing Physician Treatment Choices for Psoriatic Arthritis
© 2024 MJH Life Sciences

All rights reserved.